Evidence map›Paper›PMID 22548573›Full record

ReviewAnnals of the New York Academy of Sciences2012

Energy metabolism plasticity enables stemness programs.

Clifford D L Folmes, Timothy J Nelson, Petras P Dzeja, Andre Terzic

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cell cycle (Georgetown, Tex.) · 2022
    Article
  8. Glycolytic Profiling of Mouse Embryonic Stem Cells (mESCs).Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Review
  10. Metabolic programming of nephron progenitor cell fate.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The role of mitochondria in stem cell fate and aging.Development (Cambridge, England) · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Clifford D L FolmesCenter for Regenerative Medicine, Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota.
Timothy J NelsonCenter for Regenerative Medicine, Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota.
Petras P DzejaCenter for Regenerative Medicine, Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota.
Andre TerzicCenter for Regenerative Medicine, Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota.

Funding

Adenylate Kinase in Heart Energetics and Metabolic SignalingR01HL085744 · NHLBI · MAYO CLINIC ROCHESTER · PI DZEJA, PETRAS P · 2007 to 2016
$3.4M
Cardioprotective Repair through CardiopoiesisR01HL083439 · NHLBI · MAYO CLINIC ROCHESTER · PI TERZIC, ANDRE · 2006 to 2010
$1.8M
CIHRNHLBI NIH HHS R01 HL083439NHLBI NIH HHS R01 HL085744
6 · The paper itself

Abstract

Engineering pluripotency through nuclear reprogramming and directing stem cells into defined lineages underscores cell fate plasticity. Acquisition of and departure from stemness are governed by genetic and epigenetic controllers, with modulation of energy metabolism and associated signaling increasingly implicated in cell identity determination. Transition from oxidative metabolism, typical of somatic tissues, into glycolysis is a prerequisite to fuel-proficient reprogramming, directing a differentiated cytotype back to the pluripotent state. The glycolytic metabotype supports the anabolic and catabolic requirements of pluripotent cell homeostasis. Conversely, redirection of pluripotency into defined lineages requires mitochondrial biogenesis and maturation of efficient oxidative energy generation and distribution networks to match demands. The vital function of bioenergetics in regulating stemness and lineage specification implicates a broader role for metabolic reprogramming in cell fate decisions and determinations of tissue regenerative potential.

Indexed as

Energy MetabolismAnimalsCell DedifferentiationCell LineageCell TransdifferentiationHumansInduced Pluripotent Stem CellsRegenerationRegenerative Medicine

Identifiers

PMID22548573
PMCPMC3495059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.